Reduced m6 A levels in ADAM19 mRNA (Cui et al. 2017) and in FOXM1 (Zhang et al. 2017) promote glioma stem cell proliferation and self‐renewal and ultimately lead to tumorigenesis. Here, ADAM19 is linked to glioma.